跳至主要内容
临床试验/NCT03205228
NCT03205228已完成3 期

Treatment Outcomes in Patients With Globus: A Randomized Control Trial of Psychoeducation, Anxiolytics and Proton Pump Inhibitors

Mahidol University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年7月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Clinical improvement

研究概览

简要总结

A randomized controlled trial study is conducted to compare treatment efficacy between psycho-education, anxiolytics drug and proton pump inhibitors in participants who met the criteria of globus.

详细描述

This is a randomized controlled trial in patients with globus. All participants will be allocated into 3 groups (16 subjects/group) : Proton pump inhibitors (miracid®) , anxiolytics drug (Deanxit®) and psycho-education. The study duration is 4 weeks long.

Data regarding clinical severity and quality of life of all participants will be collected at the beginning and at the end of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Symptoms based on the following criteria: Persistent or intermittent nonpainful sensation of a lump or foreign body in the throat with no structural lesion identified on physical examination, laryngoscopy, or endoscopy.
  • Occurrence of the sensation between meals.
  • Absence of dysphagia or odynophagia

排除标准

  • Subjects with psychological disease
  • Significant heart disease and/or arrhythmia
  • Proton Pump inhibitors and/or Histamine 2 Receptor Antagonist use within 2 weeks before randomization
  • Mono-amine Oxidase inhibitors or Selective Serotonin Reuptake Inhibitor or Tricyclic antidepressant use within 2 weeks before randomization
  • History of drug allergy that use in research
  • Pregnancy or breast feeding
  • Decline to participate in study

研究组 & 干预措施

Flupentixol + Melitracen & placebo

Experimental

Deanxit® (Flupentixol + Melitracen) 5 mg/D*4 weeks will be given

干预措施: Flupentixol +Melitracen (Drug)

Proton pump inhibitor & placebo

Active Comparator

Miracid® (Omeprazole) 20 mg/D*4 weeks will be given

干预措施: Omeprazole (Drug)

Psychoeducation&placebo

Active Comparator

Psychoeducation by psychologists will be advised on Day 1 and Day 14 of the study time frame

干预措施: psychoeducation (Behavioral)

结局指标

主要结局

Clinical improvement

时间窗: 28 days

Change in clinical scores assessed by Glasgow-Edinburgh throat Scale from baseline to the endo of the study

次要结局

  • Improvement in quality of life(28 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验